IDM
Institut d' investigació
Pfizer (United States)
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Pfizer (United States) (2)
1998
-
Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires Ecto-5'-nucleotidase-mediated conversion of adenine nucleotides
Journal of Clinical Investigation, Vol. 101, Núm. 2, pp. 295-300
1996
-
The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites
Journal of Immunology, Vol. 156, Núm. 5, pp. 1937-1941